SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-010945
Filing Date
2024-02-06
Accepted
2024-02-06 08:05:29
Documents
17
Period of Report
2024-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm245249d1_8k.htm   iXBRL 8-K 48052
2 EXHIBIT 2.1 tm245249d1_ex2-1.htm EX-2.1 533185
3 EXHIBIT 10.1 tm245249d1_ex10-1.htm EX-10.1 68819
4 EXHIBIT 99.1 tm245249d1_ex99-1.htm EX-99.1 15945
  Complete submission text file 0001104659-24-010945.txt   976392

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA immu-20240205.xsd EX-101.SCH 3015
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20240205_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20240205_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT tm245249d1_8k_htm.xml XML 3611
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 24598138
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)